| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.08 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.08 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.08 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.07 | 0.08 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.074 | 0.08 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.09 |